Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

Deletion of 12p is a recurrent alteration in prostate cancer, but the prevalence and clinical consequences of this alteration have not been studied in detail. Dual labeling fluorescence in situ hybridization using probes for 12p13 (CDKN1B; p27) and centromere 12 as a reference was used to successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Kluth, Martina, Ahrary, Ramin, Hube-Magg, Claudia, Ahmed, Malik, Volta, Heinke, Schwemin, Catina, Steurer, Stefan, Wittmer, Corinna, Wilczak, Waldemar, Burandt, Eike, Krech, Till, Adam, Meike, Michl, Uwe, Heinzer, Hans, Salomon, Georg, Graefen, Markus, Koop, Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695038/
https://www.ncbi.nlm.nih.gov/pubmed/26293672

Ejemplares similares

Ejemplares similares